|
US3138588A
(en)
|
1962-08-24 |
1964-06-23 |
American Home Prod |
17-ketals of estrone and derivatives thereof
|
|
US3433785A
(en)
|
1966-07-11 |
1969-03-18 |
Sterling Drug Inc |
15,16-disubstituted aromatic steroids,intermediates and processes
|
|
US5073374A
(en)
|
1988-11-30 |
1991-12-17 |
Schering Corporation |
Fast dissolving buccal tablet
|
|
US5340586A
(en)
|
1991-04-12 |
1994-08-23 |
University Of Southern California |
Methods and formulations for use in treating oophorectomized women
|
|
JPH07101977A
(ja)
|
1993-10-05 |
1995-04-18 |
Kureha Chem Ind Co Ltd |
ホルモン作用を軽減した新規なエストラジオール誘導体及びその増殖因子阻害剤
|
|
DE4344405C2
(de)
|
1993-12-24 |
1995-12-07 |
Marika Dr Med Ehrlich |
Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption
|
|
WO1997004752A1
(en)
|
1995-07-26 |
1997-02-13 |
Duramed Pharmaceuticals, Inc. |
Pharmaceutical compositions of conjugated estrogens and methods for their use
|
|
US6117446A
(en)
|
1999-01-26 |
2000-09-12 |
Place; Virgil A. |
Drug dosage unit for buccal administration of steroidal active agents
|
|
TW548277B
(en)
|
1999-07-16 |
2003-08-21 |
Akzo Nobel Nv |
Orally active androgens
|
|
PL202999B1
(pl)
|
1999-12-02 |
2009-08-31 |
Organon Nv |
Androgeny zawierające pierścień cyklopropanowy w pozycjach 14, 15 i zastosowanie takich androgenów
|
|
US20020132801A1
(en)
|
2001-01-11 |
2002-09-19 |
Schering Aktiengesellschaft |
Drospirenone for hormone replacement therapy
|
|
EP1216713A1
(en)
|
2000-12-20 |
2002-06-26 |
Schering Aktiengesellschaft |
Compositions of estrogen-cyclodextrin complexes
|
|
US8048869B2
(en)
|
2001-05-18 |
2011-11-01 |
Pantarhei Bioscience B.V. |
Pharmaceutical composition for use in hormone replacement therapy
|
|
EP1260225A1
(en)
|
2001-05-18 |
2002-11-27 |
Pantarhei Bioscience B.V. |
A pharmaceutical composition for use in hormone replacement therapy
|
|
DK1390042T3
(da)
|
2001-05-23 |
2008-03-31 |
Pantarhei Bioscience Bv |
System for administration af et lægemiddel omfattende tetrahydroxyleret östrogen til anvendelse i hormonal svangerskabsforebyggelse
|
|
EP1390041B1
(en)
|
2001-05-23 |
2009-11-25 |
Pantarhei Bioscience B.V. |
Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
|
|
WO2003018026A1
(en)
|
2001-08-31 |
2003-03-06 |
Pantarhei Bioscience B.V. |
Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
|
|
CA2467222C
(en)
|
2001-11-15 |
2010-06-08 |
Herman Jan Tijmen Coelingh Bennink |
Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
|
|
US6723348B2
(en)
|
2001-11-16 |
2004-04-20 |
Ethypharm |
Orodispersible tablets containing fexofenadine
|
|
HU227198B1
(en)
|
2001-11-27 |
2010-10-28 |
Richter Gedeon Nyrt |
Pharmaceutical composition for emergency contraception containing levonorgestrel
|
|
CA2476940C
(en)
|
2002-02-21 |
2011-11-01 |
Herman Jan Tijmen Coelingh Bennink |
Pharmaceutical compositions comprising one or more steroids, one or more tetrahydrofolate components and vitamin b12
|
|
US20050147670A1
(en)
|
2002-05-29 |
2005-07-07 |
Impax Laboratories Inc. |
Oral disintegrating dosage forms
|
|
CN1691947B
(zh)
|
2002-06-11 |
2011-11-23 |
潘塔希生物科学股份有限公司 |
雌激素成分在制备用于治疗或预防免疫介导的疾病中的应用以及包含所述雌激素成分的药物组合物
|
|
US7943604B2
(en)
|
2002-06-11 |
2011-05-17 |
Pantarhei Bioscience B.V. |
Method of treating human skin and a skin care composition for use in such a method
|
|
CA2492287C
(en)
|
2002-07-12 |
2011-12-13 |
Pantarhei Bioscience B.V. |
Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy
|
|
RS20050184A
(sr)
|
2002-08-28 |
2007-11-15 |
Robert Casper |
Režim zamene estrogena
|
|
CN100528167C
(zh)
|
2002-10-23 |
2009-08-19 |
潘塔希生物科学股份有限公司 |
用于治疗癌症的包含雌四醇衍生物的药物组合物
|
|
AU2003278434A1
(en)
|
2002-11-05 |
2004-06-07 |
Schering Aktiengesellschaft |
Cardiovascular protection using anti-aldosteronic progestins
|
|
ATE469165T1
(de)
|
2002-11-08 |
2010-06-15 |
Pantarhei Bioscience Bv |
Synthese von oestetrol aus von oestron abgeleiteten steroiden
|
|
DK1624878T3
(da)
*
|
2003-05-22 |
2007-01-08 |
Pantarhei Bioscience Bv |
Anvendelse af præparater som omfatter en östrogen komponent til behandling og forebyggelse af muskel-skelet-smerte
|
|
PT1670440E
(pt)
|
2003-09-29 |
2014-08-22 |
Novo Nordisk Femcare Ag |
Formulações hrt
|
|
EP1673071A1
(en)
|
2003-09-29 |
2006-06-28 |
Novo Nordisk Femcare AG |
Improved stability of progestogen formulations
|
|
EP1535618A1
(en)
|
2003-11-26 |
2005-06-01 |
Schering Aktiengesellschaft |
Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions
|
|
CN1557291A
(zh)
*
|
2004-01-14 |
2004-12-29 |
杨喜鸿 |
那格列奈分散片及其制备方法
|
|
MY151322A
(en)
|
2004-04-30 |
2014-05-15 |
Bayer Ip Gmbh |
Management of breakthrough bleeding in extended hormonal contraceptive regimens
|
|
GB0410616D0
(en)
|
2004-05-13 |
2004-06-16 |
Unilever Plc |
Antiperspirant or deodorant compositions
|
|
DE102004026670A1
(de)
|
2004-05-28 |
2005-12-15 |
Grünenthal GmbH |
Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
|
|
PT1755562E
(pt)
|
2004-05-28 |
2013-12-26 |
Richter Gedeon Nyrt |
Contraceptivo contendo ácido fólico
|
|
UA89964C2
(ru)
|
2004-09-08 |
2010-03-25 |
Н.В. Органон |
15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
|
|
JP5268635B2
(ja)
|
2005-05-26 |
2013-08-21 |
アボット プロダクツ ゲゼルシャフト ミット ベシュレンクテル ハフツング |
１７β−ＨＳＤ１及びＳＴＳインヒビター
|
|
US20070048369A1
(en)
|
2005-08-26 |
2007-03-01 |
National Starch And Chemical Investment Holding Corporation |
Mucosal delivery tablet
|
|
CA2636638C
(en)
|
2006-01-09 |
2014-02-18 |
Pantarhei Bioscience B.V. |
A method of treating an acute vascular disorder
|
|
CA2640520C
(en)
|
2006-03-02 |
2014-04-22 |
Warner Chilcott Company, Inc. |
Extended cycle multiphasic oral contraceptive method
|
|
US20070286819A1
(en)
|
2006-06-08 |
2007-12-13 |
Warner Chilcott Company, Inc. |
Methods to administer ethinyl estradiol and prodrugs thereof with improved bioavailability
|
|
US20080113953A1
(en)
|
2006-06-08 |
2008-05-15 |
Warner Chilcott Company, Inc. |
Methods to administer solid dosage forms of ethinyl estradiol and prodrugs thereof with improved bioavailability
|
|
ES2659316T3
(es)
|
2006-06-08 |
2018-03-14 |
Allergan Pharmaceuticals International Limited |
Procedimientos para administrar formas de dosificación sólidas de etinilestradiol y profármacos del mismo con biodisponibilidad mejorada
|
|
CA2665788A1
(en)
|
2006-07-06 |
2008-01-10 |
Bayer Schering Pharma Aktiengesellschaft |
Pharmaceutical preparations for contraception and for preventing the risk of congenital malformations
|
|
CN101489563A
(zh)
|
2006-07-06 |
2009-07-22 |
拜耳先灵医药股份有限公司 |
用于避孕和预防先天性畸形风险的药物制剂
|
|
CA2670544A1
(en)
|
2006-11-29 |
2008-06-05 |
Wyeth |
Estrogen/ serm and estrogen/ progestin bi-layer tablets
|
|
CA2674776A1
(en)
|
2006-12-20 |
2008-07-03 |
Duramed Pharmaceuticals, Inc. |
Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
|
|
US8236785B2
(en)
|
2007-01-08 |
2012-08-07 |
Pantarhei Bioscience B.V. |
Method of treating or preventing infertility in a female mammal and pharmaceutical kit for use in such method
|
|
PE20081632A1
(es)
|
2007-01-12 |
2008-12-10 |
Wyeth Corp |
Composiciones de tableta en tableta
|
|
CN102014924B
(zh)
|
2007-06-21 |
2012-07-18 |
潘塔希生物科学股份有限公司 |
用雌激素治疗胎粪吸入综合征
|
|
WO2009011576A1
(en)
|
2007-07-19 |
2009-01-22 |
Pantarhei Bioscience B.V. |
Treatment or prevention of hypertensive disorders of pregnancy or fetal growth retardation
|
|
JP5399749B2
(ja)
*
|
2008-03-27 |
2014-01-29 |
沢井製薬株式会社 |
プロトンポンプ阻害剤を含有する被覆微粒子
|
|
US20110250274A1
(en)
|
2008-09-19 |
2011-10-13 |
Shaked Ze Ev |
Estriol formulations
|
|
DE102009007771B4
(de)
|
2009-02-05 |
2012-02-16 |
Bayer Schering Pharma Aktiengesellschaft |
Bukkales Applikationssystem, 17α-Estradiol enthaltend
|
|
NZ597239A
(en)
|
2009-06-23 |
2013-07-26 |
Bayer Pharma AG |
Pharmaceutical composition for emergency contraception
|
|
CN102058604A
(zh)
|
2009-11-17 |
2011-05-18 |
北京万全阳光医学技术有限公司 |
一种含有地诺孕素和戊酸雌二醇的药物组合物及其制备方法
|
|
MX356702B
(es)
|
2010-04-15 |
2018-06-11 |
Bayer Ip Gmbh |
Formas de dosificación sólidas orales con dosis muy bajas para la hrt.
|
|
AR081670A1
(es)
|
2010-06-29 |
2012-10-10 |
Leon Farma Sa Lab |
Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
|
|
US10849857B2
(en)
|
2010-07-28 |
2020-12-01 |
Laboratorios Leon Farma Sa |
Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
|
|
US9603860B2
(en)
|
2010-07-28 |
2017-03-28 |
Laboratorios Leon Farma Sa |
Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
|
|
WO2012055840A1
(en)
|
2010-10-28 |
2012-05-03 |
Bayer Pharma Aktiengesellschaft |
Composition and preparation for treatment of dysmenorrhea and menstrual pain and use of a hormonal agent and a zinc salt for treatment of menstrual disorders
|
|
JP2012240917A
(ja)
|
2011-05-16 |
2012-12-10 |
Zensei Yakuhin Kogyo Kk |
製剤化用微粒子とそれを含む製剤
|
|
PT2714710T
(pt)
|
2011-06-01 |
2016-07-12 |
Estetra Sprl |
Processo para a produção de intermediários de estetrol
|
|
AU2012264601C1
(en)
|
2011-06-01 |
2018-01-25 |
Estetra Srl |
Process for the production of estetrol intermediates
|
|
EP2383279A1
(en)
|
2011-07-19 |
2011-11-02 |
Pantarhei Bioscience B.V. |
Process for the preparation of estetrol
|
|
WO2013012326A1
(en)
|
2011-07-19 |
2013-01-24 |
Pantarhei Bioscience B.V. |
Tablet containing dehydroepiandrosterone (dhea)
|
|
HRP20170797T1
(hr)
|
2011-08-11 |
2017-08-11 |
Estetra S.P.R.L. |
Primjena estetrola kao hitnog kontraceptiva
|
|
NZ620897A
(en)
|
2011-09-16 |
2016-07-29 |
Ferring Bv |
A fast dissolving pharmaceutical composition
|
|
EP2764008B1
(en)
|
2011-10-07 |
2016-08-17 |
Estetra S.P.R.L. |
Process for the production of estetrol
|
|
WO2013090117A1
(en)
|
2011-12-13 |
2013-06-20 |
Arstat, Inc. |
A multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogen
|
|
EP2653163A1
(en)
|
2012-04-19 |
2013-10-23 |
Université de Liège |
Estrogenic components for use in the treatment of neurological disorders
|
|
US9808470B2
(en)
|
2012-04-19 |
2017-11-07 |
Universite De Liege |
Estrogenic components for use in the treatment of neurological disorders
|
|
WO2014159377A1
(en)
|
2013-03-14 |
2014-10-02 |
Teva Women's Health, Inc. |
Compositions containing tanaproget and natural estrogens
|
|
JP6126456B2
(ja)
*
|
2013-05-17 |
2017-05-10 |
東和薬品株式会社 |
打錠用顆粒とその製造方法、その打錠用顆粒を用いた口腔内崩壊錠
|
|
JP2016520590A
(ja)
|
2013-05-21 |
2016-07-14 |
プレディクティヴ セラピューティクス, リミテッド ライアビリティー カンパニーPredictive Therapeutics, LLC |
治療薬および使用法
|
|
CA2924255C
(en)
|
2013-09-18 |
2022-11-22 |
Crystal Pharma, S.A.U. |
Process for the preparation of estetrol
|
|
KR102265150B1
(ko)
|
2013-12-12 |
2021-06-16 |
에스테트라 에스.피.알.엘. |
에스테트롤 성분을 함유하는 구강 붕해성 고체 투여 단위
|
|
WO2016023009A1
(en)
|
2014-08-07 |
2016-02-11 |
Wake Forest University Health Sciences |
Compositions and methods for clearing a biological sample
|
|
EP3200802B1
(en)
|
2014-09-29 |
2023-07-12 |
The Regents of The University of California |
Compositions and methods for maintaining cognitive function
|
|
WO2016187269A1
(en)
|
2015-05-18 |
2016-11-24 |
Agile Therapeutics, Inc. |
Contraceptive compositions and methods for improved efficacy and modulation of side effects
|
|
MY195019A
(en)
|
2015-06-18 |
2023-01-03 |
Estetra Sprl |
Orodispersible dosage unit containing an estetrol component
|
|
MD3310346T2
(ro)
|
2015-06-18 |
2021-06-30 |
Estetra Sprl |
Comprimată orodispersabilă ce conține estetrol
|
|
JP6866560B2
(ja)
|
2015-06-18 |
2021-04-28 |
エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ |
エステトロール成分を含有する口腔内崩壊性投与単位
|
|
HUE054589T2
(hu)
|
2015-06-18 |
2021-09-28 |
Estetra Sprl |
Szájban diszpergálódó esztetrol tartalmú tabletta
|
|
MX389310B
(es)
|
2015-06-23 |
2025-03-20 |
Laboratorios Leon Farma Sa |
Anticonceptivos a base de drospirenona para paciente femenina afectada con exceso de peso.
|
|
US20200046729A1
(en)
|
2016-08-05 |
2020-02-13 |
Estetra Sprl |
Methods using combined oral contraceptive compositions with reduced cardiovascular effects
|
|
KR102712911B1
(ko)
|
2016-08-05 |
2024-10-04 |
에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 |
월경통 및 생리통의 관리방법
|
|
CN111683664A
(zh)
|
2018-02-07 |
2020-09-18 |
埃斯特拉私人有限责任公司 |
具有降低的心血管作用的避孕组合物
|